CA2101846A1 - Defibrillation lead system and method of use - Google Patents
Defibrillation lead system and method of useInfo
- Publication number
- CA2101846A1 CA2101846A1 CA002101846A CA2101846A CA2101846A1 CA 2101846 A1 CA2101846 A1 CA 2101846A1 CA 002101846 A CA002101846 A CA 002101846A CA 2101846 A CA2101846 A CA 2101846A CA 2101846 A1 CA2101846 A1 CA 2101846A1
- Authority
- CA
- Canada
- Prior art keywords
- electrode
- lead
- electrodes
- heart
- defibrillation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3918—Heart defibrillators characterised by shock pathway, e.g. by electrode configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/395—Heart defibrillators for treating atrial fibrillation
Abstract
A method of cardioverting the atrium of a human heart, comprising insertion of first and second elongated electrodes transvenously into the heart and associated vessels. One electrode (212) is preferably located in the coronary sinus and great vein of the heart. The other electrode (206) is preferably located in the vicinity of the atrium of the heart, spaced from the electrode located in the coronary sinus. In response to detection of fibrillation or in response to manual triggering, a defibrillation pulse is applied between the first and second electrodes (212, 206) to effect atrial cardioversion.
Description
2 PCI`/US91/08665 21018~6 DEP'I~RII.S~T~ON ~E~D 8Y8~EM
AND ME~Qp OF ~
BACKGROUND OF THE INVENTION
The present invention relates to medical electrical leads generally, and more particularly to implantable defibrillation electrodes and leads.
Early concepts o~ impla~table defibrillators, such as disclosed in Reissue Patent No. 27,652 by Mirowski, et al, en~ision an electrode system employing a ventricular endocardial electrode and a plate electrode mounted to the heart directly, subcutaneously, or to the skin. However, it has long been recognized that a totally transvenous system would be desirable in order to simply the use of implantable defibrillators. One such system is suggested in U.S. Patent No. 3,942,536 by Mirowski, et al, which discloses a transvenous lead having electrodes intended ~or location in -~ the right ventricular apex and in the superior vena cava.
This electrode system is disclosed as useful for either ventricular or atrial defibrillation. Such systems were eventually tested in human beings, with some success.
However, currently available implantable defibrillators typically employ epicardial patch electrodes, alone, or in - con~unction with transvenous electrodes.
While systems employing epicardial patch electrodes are workable, a thoracotomy is required in order to apply the epicardial electrode~. It is generally belie~ed that it would be desirable to produce an imPlantable defibrillation system which entirely avoids the necessity of a thoracotomy, and there has ~een substantial work directed towards development of such systems, as disclosed in U.S. Patent No.
4,727,877 issued to Kallok, U.S. Patent No. 4,708,145 issued to Tacker, et al, and as disclosed in U.S. Application Serial No. 07/284,957 filed December 15, 1988 by Mehra, for ,.
WO 92/14512 21~,1,8"~ 2 PCT/US91/~K~
an "Endocardial Defibrillation Electrode System". other endocardial defibrillation electrodes are disclosed in U.S;
Patent No. 4,481,953 issued to Gold et al, U.s. Patent No.
4,161,952 issued to Kinney, et al, U.S. Patent No. 4,934,049 S issued to Kiekhafer et al and in U. S. Patent Application Serial No. 07/479,928, filed February 14, 1990 by Holleman, et al, for an "Implantable Electrode and Method for Fabrication". The Xinney, Gold and Kiekhafer patents and the Holleman, et al application all disclose endocardial defibrillation leads employing defibrillation electrodes fabricated from elongated coils of biocompatible metal, mounted exposed to the exterior of the defibrillation lead, for location in the right ventricle and other locations within the heart. The above-cited Smits patent and the Mehra application both disclose a variety of endocardial defibrillation electrodes intended for use in the atrium, ventricle and coronary sinus, all of which employ electrodes taking the form of elongated coils of condu~tive biocompatible metals.
~- 20 Concurrent with the development of lead systems adapted to treat ventricular fibrillation, there has also been some work directed to the development of lead systems to treat atrial fibrillation. Synchronized cardioversion using two electrodes lo¢ated on a lead located in the right atrium is ; 25 disclosed in U.S. Patent No. 3,738,370, issued to Charms. A
later system is disclosed in U.S. Patent No. 3,952,750, issued to Mirowski et al, employing one electrode in the atrium and presumably a second electrode at an unspecified location. Neither of these references discloses a specific ~ 30 embodiment for the electrodes located in the atrium.
i An electrode lead system specifically designed for atrial defibrillation is disclosed in the article "Elective Countershock in Atrial Fibri}lation With an Intracardiac Electrode - A Preliminary Report, by Jain, et al, published in the Journal of the Association of Phvsicians of India, Vol. 18, pp 821-824, I970. This lead was provided with a 10 WO92/14512 PCT/US9l/~
2101~
---mm silver electrode for location in the right atrium and was tested in conjunction with either a second electrode located in the right a~rium or a second, cutaneous electrode located on the left side of the chest wall~ A second electrode system specific~lly designed for use in atrial cardioversion is disclosed in the article ~Safety and feasibility of transvenous cardioversion in atrial tachycardia", by Blanc et al, published in Cardiac Pacinq, edited by Gomez, Futura Pub. Co., 1985, pp 1526-1529. This electrode system employed a single lead with electrodes located in the atrium and pulmonary artexy.
SUMMARY OF THE INVEN~ON
The present invention is directed toward the provision of an entirely endocardial defibrillation lead system particularly optimized for use in defibrillation or cardioversion of the atriumr ~owever, the lead system may also be used in conjunction with other endocardial electrodes adapted to effect ventricular defibrillation.
The system disclo~ed includes coronary sinus and right atrial electrodes, and may be embodied with the electrodes located on the sa~e or different lead bodies.
Also disclosed are embodiments in which a ~entricular electrode is provided so that defibrillation or cardioversion pulses may ~e delivered between the right ventricle and the coronary sinus electrode. In such embodiments, the atrial electrode may be located on the same lead as the coronary ~inus or right ventricular electrode, or may be located on a separate lead.
BRIEF DESCRIPTION OF THE DRAWINGS
- Fig. 1 illustrates a first embodiment of a cardioversion/defibrillation lead system according to the present invention employing a J-s~aped atrial electrode 3S located on a lead also provided with a pair of electrodes WO 92/14512 2 1 Q 1 8, 4 6 PCT/US91/~
including a helical electrode for affixing the lead to the atrial wall and a separate lead carrying the coronary sinus electrode.
Fig. 2 illustrates a second embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a generally straight. atrial electrode, not actively affixed to the atrial wall.
Fig. 3 illustrates a third embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a lead carrying both the coronary sinus electrode and the atrial electrode in conjunction with a ventricular defibrillation lead.
Fig. 4 illustrates a fourth embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a lead carrying both a ventricular electrode and the atrial electrode in conjunction with a separate lead carrying the coronary sinus electrode.
; ~ETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTSFigure 1 is a cutaway view of the hu~an heart in which a lead system embodying the present invention has been implanted. ~he lead system includes two leads, one having its electrode located in the right atrium, the other having its electrode located in the coronary sinus. The right atrial lead lOl employs an elongated insulative lead body 102, to which a coiled defibrillation electrode 106 has been mounted- The distal end of the lead includes an electrode head lll, carrying a helical electrode llO and a ring electrode 108. The electrodes 106, 108 and llO are coupled to an implantable defibrillator/cardioverter lOO by means of conductors 116, 118 and 120. The coronary sinus lead ?03 ~ also has an elongated insulative lead body 104 which carries a 35 a coiled defibrillation electrode at its distal end, located ~' !
WO 92/14512 2 1 0 1 ~ 4 6 PCT/US91/0&~
s as generally indicated in broken outline at 112. Electrode 112 is located within the coronary sinus and the great cardiac vein. Preferably the proximal end of the electrode 112 is spaced about 3 to 8 cm from the opening of the coronary sinus into the right atrium. The curved configuration of lead 101 assists in providing an adequate surface area electrode within the atrium and the fixation helix assists in keeping the electrode 106 ~paced from the opening of the coronary sinus. Depending on the size and configuration of the patient's heart, it is anticipated that the electrode 106 may extend into the superior vena cava or may be located predominantly in the superior vena cava.
~aintaining an appropriate spacing between the electrodes 112 and 106 is important to avoid areas of excessive current density in the regions of their closest proximity~
The electrode 112 is coupled to an implantable defibrillator cardioverter lO0 by means of conductor 122.
Electrodes 108 and llO are used by defibrillator cardiovertor 100 to sense the electrical activity of the atrium and to diagnose the presence of atrial tachycardias or atrial fibrillations requiring cardioversion or defibrillation, respectively. In response to the detection of tachycardia or fibrillation, defibrillator/cardioverter 100 generates a high voltage pulse between electrodes 106 and 112.
Lead body 102 contains 3 concentric coiled conductors 116, 118, 120, illustrated schematically. These three conductors are separated from one another by tubular insulative sheaths. This tripolar arrangement is illustrated in more detail in U.S. Patent No. 4,355,646, issued to Kallok, et al, incorporated herein by reference in its entirety. As set forth in the cited hallok, et al patent, the insulative sheaths employed in the present lead may be made of an implantable polyurethane. However, in some embodiments, the sheaths may be made of silicone rubber WO92/14512 PCT/US91/Q&~
2 1 ~ ` 6 or other implantable, flexible plastic. The conductor coils may be made of Drawn Brazed Strand wire (DBS), previously used in cardiac pacing leads or may be another implantable metal such as MP35N alloy, also commonly used in pacing leads.
The outermost of the three conductor coils within lead body 102 is coupled to the proximal end of electrode coil 106 and the middle coil within sheath 102 is coupled to ring electrode 108. The innermost coil within lead body 102 is mounted rotatably within an insulative sheath separating the innermost coil from the middle coil, and is mechanically and electrically coupled to helical electrode 110, which is retractably mounted within electrode head 111. Rotation of the innermost conductor coil causes rotation of electrode 110 and advancement of electrode 110 out the distal end of electrode head 111. Electrode 110 may be screwed into the tissue of the right atrial appendage of the heart, and is used to anchor the lead. The electrode head 111, electrode 110, and the inner most conductor coil emp~oyed to rotate the helical electrode 110 are described in more detail in U.S. Pat~nt No. 4,106,512, issued August 15, 1978 to Bisping, incorporated herein by reference in its entirety.
Lead body 104 contains a single coiled conductor, coupled to the proximal end of an electrode coil illustrated in broken outline at 112. This conductor coil may optionally extend within sheath to ~he proximal end o~ the lead, and may.also be coupled to the distal end of the electrode 112. At the distal end of the lead is an insulative plastic tip, not visible in this view.
Electrodes 106 and 112 may be mounted around insulative - lead bodies 102 and 104 and bonded to them by means of a backfill of insulative plastic, as des~ribed in U.S. Patent No. 4,934,049 issued to Xiekhafer, et al, on June 19, 1990, and incorporated herein by reference in its entirety. As an alt-rnative, the insulative lead bodies 102 and 104 may be , ,~
WO 92/14512 2 1 0 1 8 ~ ~ ~ PCT/USg~/O~
fabricated of a polyurethane or other heat flowable ~
material, expanded against the interior of the electrode coils under pressure and heat to allow the material of the sheath to flow between the electrode coils, as illustrated in U.S. Patent Application Serial No. 07t479,928, filed on February 14, l990 for an "Implantable Electrode ~nd Method for Fabrication1' by Holleman, et al, also incorporated herein by reference in its entirety. Alternatively, the electrode coils may be fabricated using the techniques illustrated in the above cited Kinney or Gold patents.
Electrodes 30 and 32 are preferably made of platinum.
However, as discussed in the references cited above, other implantable metals have been disclosed for use in such electrodes.
The curved configuration of electrode 106 as illustrated is maintained by any of a num~er of known mechanisms. It may be maintained by means of molding lead body 102 in the form of a curved tube, or otherwise imparting a predetermined curve thereto. For example, the techniques illustrated in U.S. Patent No. 3,729,008 issued to Berkovitz, also incorporated herein by reference in its entirety may ba adapted. Alternatively, the electrode coil 106 may ~e preformed to exhibit a curved configuration. An additio~al preformed curved coil devoted particularly to maintaining the curved configuration of the lead may also be used, as disclosed in U.S. Patent No. 4,402,330, issued on September 6, 1983 to Lindemans, also incorporated herein by reference in its entirety.
A specific example of a defibrillation pulse generator which may be used in conjunction with the present lead is disclosed in U.S. Patent No. 4,953,551, issued to Mehra et al on September 4, l9so, incorporated herein by reference in its entirety. An addition example of an appropriate pulse generator is disclosed in U.S. Patent Application Serial No.
07/612,758 for an "Apparatus for Delivering Single &
.
WO 92/14512 21 01~3 4~6 8 PCT/US91/0~
Multiple Cardioversion Pulses", filed November 14, 19gO, by Keimel and also incorporate~ herein by reference in its entirety.
While it is envisioned that the present application may most beneficially be practiced in conjunction with an implantable cardioverter/defibrillator which has the capability of sensing the electrical activity of the heart to detect the presence of atrial tachycardia or fibrillation, the invention may also be usefully practiced in conjunction with a device as disclosed in U.S Patent No.
AND ME~Qp OF ~
BACKGROUND OF THE INVENTION
The present invention relates to medical electrical leads generally, and more particularly to implantable defibrillation electrodes and leads.
Early concepts o~ impla~table defibrillators, such as disclosed in Reissue Patent No. 27,652 by Mirowski, et al, en~ision an electrode system employing a ventricular endocardial electrode and a plate electrode mounted to the heart directly, subcutaneously, or to the skin. However, it has long been recognized that a totally transvenous system would be desirable in order to simply the use of implantable defibrillators. One such system is suggested in U.S. Patent No. 3,942,536 by Mirowski, et al, which discloses a transvenous lead having electrodes intended ~or location in -~ the right ventricular apex and in the superior vena cava.
This electrode system is disclosed as useful for either ventricular or atrial defibrillation. Such systems were eventually tested in human beings, with some success.
However, currently available implantable defibrillators typically employ epicardial patch electrodes, alone, or in - con~unction with transvenous electrodes.
While systems employing epicardial patch electrodes are workable, a thoracotomy is required in order to apply the epicardial electrode~. It is generally belie~ed that it would be desirable to produce an imPlantable defibrillation system which entirely avoids the necessity of a thoracotomy, and there has ~een substantial work directed towards development of such systems, as disclosed in U.S. Patent No.
4,727,877 issued to Kallok, U.S. Patent No. 4,708,145 issued to Tacker, et al, and as disclosed in U.S. Application Serial No. 07/284,957 filed December 15, 1988 by Mehra, for ,.
WO 92/14512 21~,1,8"~ 2 PCT/US91/~K~
an "Endocardial Defibrillation Electrode System". other endocardial defibrillation electrodes are disclosed in U.S;
Patent No. 4,481,953 issued to Gold et al, U.s. Patent No.
4,161,952 issued to Kinney, et al, U.S. Patent No. 4,934,049 S issued to Kiekhafer et al and in U. S. Patent Application Serial No. 07/479,928, filed February 14, 1990 by Holleman, et al, for an "Implantable Electrode and Method for Fabrication". The Xinney, Gold and Kiekhafer patents and the Holleman, et al application all disclose endocardial defibrillation leads employing defibrillation electrodes fabricated from elongated coils of biocompatible metal, mounted exposed to the exterior of the defibrillation lead, for location in the right ventricle and other locations within the heart. The above-cited Smits patent and the Mehra application both disclose a variety of endocardial defibrillation electrodes intended for use in the atrium, ventricle and coronary sinus, all of which employ electrodes taking the form of elongated coils of condu~tive biocompatible metals.
~- 20 Concurrent with the development of lead systems adapted to treat ventricular fibrillation, there has also been some work directed to the development of lead systems to treat atrial fibrillation. Synchronized cardioversion using two electrodes lo¢ated on a lead located in the right atrium is ; 25 disclosed in U.S. Patent No. 3,738,370, issued to Charms. A
later system is disclosed in U.S. Patent No. 3,952,750, issued to Mirowski et al, employing one electrode in the atrium and presumably a second electrode at an unspecified location. Neither of these references discloses a specific ~ 30 embodiment for the electrodes located in the atrium.
i An electrode lead system specifically designed for atrial defibrillation is disclosed in the article "Elective Countershock in Atrial Fibri}lation With an Intracardiac Electrode - A Preliminary Report, by Jain, et al, published in the Journal of the Association of Phvsicians of India, Vol. 18, pp 821-824, I970. This lead was provided with a 10 WO92/14512 PCT/US9l/~
2101~
---mm silver electrode for location in the right atrium and was tested in conjunction with either a second electrode located in the right a~rium or a second, cutaneous electrode located on the left side of the chest wall~ A second electrode system specific~lly designed for use in atrial cardioversion is disclosed in the article ~Safety and feasibility of transvenous cardioversion in atrial tachycardia", by Blanc et al, published in Cardiac Pacinq, edited by Gomez, Futura Pub. Co., 1985, pp 1526-1529. This electrode system employed a single lead with electrodes located in the atrium and pulmonary artexy.
SUMMARY OF THE INVEN~ON
The present invention is directed toward the provision of an entirely endocardial defibrillation lead system particularly optimized for use in defibrillation or cardioversion of the atriumr ~owever, the lead system may also be used in conjunction with other endocardial electrodes adapted to effect ventricular defibrillation.
The system disclo~ed includes coronary sinus and right atrial electrodes, and may be embodied with the electrodes located on the sa~e or different lead bodies.
Also disclosed are embodiments in which a ~entricular electrode is provided so that defibrillation or cardioversion pulses may ~e delivered between the right ventricle and the coronary sinus electrode. In such embodiments, the atrial electrode may be located on the same lead as the coronary ~inus or right ventricular electrode, or may be located on a separate lead.
BRIEF DESCRIPTION OF THE DRAWINGS
- Fig. 1 illustrates a first embodiment of a cardioversion/defibrillation lead system according to the present invention employing a J-s~aped atrial electrode 3S located on a lead also provided with a pair of electrodes WO 92/14512 2 1 Q 1 8, 4 6 PCT/US91/~
including a helical electrode for affixing the lead to the atrial wall and a separate lead carrying the coronary sinus electrode.
Fig. 2 illustrates a second embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a generally straight. atrial electrode, not actively affixed to the atrial wall.
Fig. 3 illustrates a third embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a lead carrying both the coronary sinus electrode and the atrial electrode in conjunction with a ventricular defibrillation lead.
Fig. 4 illustrates a fourth embodiment of a cardioversion/defibrillation lead system according to the present invention, employing a lead carrying both a ventricular electrode and the atrial electrode in conjunction with a separate lead carrying the coronary sinus electrode.
; ~ETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTSFigure 1 is a cutaway view of the hu~an heart in which a lead system embodying the present invention has been implanted. ~he lead system includes two leads, one having its electrode located in the right atrium, the other having its electrode located in the coronary sinus. The right atrial lead lOl employs an elongated insulative lead body 102, to which a coiled defibrillation electrode 106 has been mounted- The distal end of the lead includes an electrode head lll, carrying a helical electrode llO and a ring electrode 108. The electrodes 106, 108 and llO are coupled to an implantable defibrillator/cardioverter lOO by means of conductors 116, 118 and 120. The coronary sinus lead ?03 ~ also has an elongated insulative lead body 104 which carries a 35 a coiled defibrillation electrode at its distal end, located ~' !
WO 92/14512 2 1 0 1 ~ 4 6 PCT/US91/0&~
s as generally indicated in broken outline at 112. Electrode 112 is located within the coronary sinus and the great cardiac vein. Preferably the proximal end of the electrode 112 is spaced about 3 to 8 cm from the opening of the coronary sinus into the right atrium. The curved configuration of lead 101 assists in providing an adequate surface area electrode within the atrium and the fixation helix assists in keeping the electrode 106 ~paced from the opening of the coronary sinus. Depending on the size and configuration of the patient's heart, it is anticipated that the electrode 106 may extend into the superior vena cava or may be located predominantly in the superior vena cava.
~aintaining an appropriate spacing between the electrodes 112 and 106 is important to avoid areas of excessive current density in the regions of their closest proximity~
The electrode 112 is coupled to an implantable defibrillator cardioverter lO0 by means of conductor 122.
Electrodes 108 and llO are used by defibrillator cardiovertor 100 to sense the electrical activity of the atrium and to diagnose the presence of atrial tachycardias or atrial fibrillations requiring cardioversion or defibrillation, respectively. In response to the detection of tachycardia or fibrillation, defibrillator/cardioverter 100 generates a high voltage pulse between electrodes 106 and 112.
Lead body 102 contains 3 concentric coiled conductors 116, 118, 120, illustrated schematically. These three conductors are separated from one another by tubular insulative sheaths. This tripolar arrangement is illustrated in more detail in U.S. Patent No. 4,355,646, issued to Kallok, et al, incorporated herein by reference in its entirety. As set forth in the cited hallok, et al patent, the insulative sheaths employed in the present lead may be made of an implantable polyurethane. However, in some embodiments, the sheaths may be made of silicone rubber WO92/14512 PCT/US91/Q&~
2 1 ~ ` 6 or other implantable, flexible plastic. The conductor coils may be made of Drawn Brazed Strand wire (DBS), previously used in cardiac pacing leads or may be another implantable metal such as MP35N alloy, also commonly used in pacing leads.
The outermost of the three conductor coils within lead body 102 is coupled to the proximal end of electrode coil 106 and the middle coil within sheath 102 is coupled to ring electrode 108. The innermost coil within lead body 102 is mounted rotatably within an insulative sheath separating the innermost coil from the middle coil, and is mechanically and electrically coupled to helical electrode 110, which is retractably mounted within electrode head 111. Rotation of the innermost conductor coil causes rotation of electrode 110 and advancement of electrode 110 out the distal end of electrode head 111. Electrode 110 may be screwed into the tissue of the right atrial appendage of the heart, and is used to anchor the lead. The electrode head 111, electrode 110, and the inner most conductor coil emp~oyed to rotate the helical electrode 110 are described in more detail in U.S. Pat~nt No. 4,106,512, issued August 15, 1978 to Bisping, incorporated herein by reference in its entirety.
Lead body 104 contains a single coiled conductor, coupled to the proximal end of an electrode coil illustrated in broken outline at 112. This conductor coil may optionally extend within sheath to ~he proximal end o~ the lead, and may.also be coupled to the distal end of the electrode 112. At the distal end of the lead is an insulative plastic tip, not visible in this view.
Electrodes 106 and 112 may be mounted around insulative - lead bodies 102 and 104 and bonded to them by means of a backfill of insulative plastic, as des~ribed in U.S. Patent No. 4,934,049 issued to Xiekhafer, et al, on June 19, 1990, and incorporated herein by reference in its entirety. As an alt-rnative, the insulative lead bodies 102 and 104 may be , ,~
WO 92/14512 2 1 0 1 8 ~ ~ ~ PCT/USg~/O~
fabricated of a polyurethane or other heat flowable ~
material, expanded against the interior of the electrode coils under pressure and heat to allow the material of the sheath to flow between the electrode coils, as illustrated in U.S. Patent Application Serial No. 07t479,928, filed on February 14, l990 for an "Implantable Electrode ~nd Method for Fabrication1' by Holleman, et al, also incorporated herein by reference in its entirety. Alternatively, the electrode coils may be fabricated using the techniques illustrated in the above cited Kinney or Gold patents.
Electrodes 30 and 32 are preferably made of platinum.
However, as discussed in the references cited above, other implantable metals have been disclosed for use in such electrodes.
The curved configuration of electrode 106 as illustrated is maintained by any of a num~er of known mechanisms. It may be maintained by means of molding lead body 102 in the form of a curved tube, or otherwise imparting a predetermined curve thereto. For example, the techniques illustrated in U.S. Patent No. 3,729,008 issued to Berkovitz, also incorporated herein by reference in its entirety may ba adapted. Alternatively, the electrode coil 106 may ~e preformed to exhibit a curved configuration. An additio~al preformed curved coil devoted particularly to maintaining the curved configuration of the lead may also be used, as disclosed in U.S. Patent No. 4,402,330, issued on September 6, 1983 to Lindemans, also incorporated herein by reference in its entirety.
A specific example of a defibrillation pulse generator which may be used in conjunction with the present lead is disclosed in U.S. Patent No. 4,953,551, issued to Mehra et al on September 4, l9so, incorporated herein by reference in its entirety. An addition example of an appropriate pulse generator is disclosed in U.S. Patent Application Serial No.
07/612,758 for an "Apparatus for Delivering Single &
.
WO 92/14512 21 01~3 4~6 8 PCT/US91/0~
Multiple Cardioversion Pulses", filed November 14, 19gO, by Keimel and also incorporate~ herein by reference in its entirety.
While it is envisioned that the present application may most beneficially be practiced in conjunction with an implantable cardioverter/defibrillator which has the capability of sensing the electrical activity of the heart to detect the presence of atrial tachycardia or fibrillation, the invention may also be usefully practiced in conjunction with a device as disclosed in U.S Patent No.
3,952,750, issued to Mirowski et al. on April 27, 1976, incorporated herein by reference in its entirety. In devices as illustrated in the Mirowski et al. patent, the detection of atrial fi~rillation is not accomplished by the implanted device. Instead, the presence of atrial fibrillation is detected either by a physician or the patient, and a signal is generated external to the device, triggering delivery of a synchronized atrial defibrillation pulse. This approach is made possible by the fsct that atrial fi~rillation, unlike ventricular fibrillation, does not result in the cessation of the heart's pumping action.
Figure 2 is a cutaway view of the h~man heart illustrating an alternative embodiment of the present invention employing an atrial lead having a generally straight defibrillation electrode 206 and a coronary sinus defibrillation lead 203 provided with sensing electrodes 208 and 210. The electrode lead 203 may correspond to the coronary sinus defibrillation lead illustrated in F~gure 2 of allowed U.S. Patent Application Serial No. 07/284,957, filed December 15, 19~8 by Mehra, for an "Endocardial Defibrillation Electrode System" incorporated herein by reference. LiXe the atrial lead lOl discussed in conjunction with Figure l, lead 203 has a tripolar configuration, employing three coaxial conductors 116, 118 and 120, each coupled to one of electrodes 208, 210 and WO 92/14512 21 018 4 ~ PCT/US91/08 ~
electrode 2~2, indicated in broken out line within the coronary sinus. Electrodes 208 and 210 function to sense the electrical activity of the atrium for defibrillation detection and/or cardiac pacing.
Electrode lead 201 corresponds to the lead illustrated in Figure 2 of the above-cited allowed application by Mehra et al., however it omits sensing electrodes corresponding to electrodes 208 and 2lO, and includes only a single conductor 122, mounted within insulative lead body 202, coupled to electrodes 206. A pliant insulative tip 124 is visible. A
corresponding pliant, insulative tip is located on the distal end of lead 203, not visible in this view and on the distal end of lead lOl, Fig. l. As in the case of electrode 106, Fig. l, electrode 206 may extend proximally into the superior vena cava or may be located predominantly in the superior vena cava.
The construction of electrodes 206 and 212 corresponds to the construction of electrodes 106 and ll~, as discussed above in conjunction with Figure l. As in the case of the system illustrated in Figure l, defibrillatortcardioverter 200 delivers defibrillation pulses between electrodes 206 and 212, either in response to detection of atrial tachycardia or fibrillation via electrodes 208 and 210 or in response to an external command signal.
Figure 3 is a cutaway view of the heart illustrating yet another embodiment of an electrode ~ystem embodying the present invention . In this embodiment, a first electrode , lead 301 is pro~ided with two defibrillation electrodes 306 and 312, both located around its insulative lead body 302.
Lead 301 is a bipolar lead, employing two conductors 320 and 322 located coaxially within lead body 302. Electrodes 306 and 312 may correspond to electrodes 106 ~d 112, illustrated in Figure l. Electro~e 306 is provided with a preformed, J-shaped configuration corresponding to that of electrode 106, illustrated in Figure l which assists both in ., , ~J
, ~ , . _ .
f , .
;:~
21 D 1 ~ 4 6 PCT/US91/08 ~
~aintaining the lead in its location within the heart and allows for a substantial surface area of the electrode 306 to be located in the right atrium, while remaining spaced from the ostium of the coronary sinus. Electrode 312 is located within the coronary sinus and great vein also, spaced from the ostium of the coronary sinus. An interelectrode spacing of at least about 5_cm is believed desirable. This assists in providing good intraelectrode separation between electrode 306 and 312. As a practical matter, this interelectrode spacing may result in electrode 306 being predominantly located in the superior vena cava in some patients.
A second lead 303 is provided which is also triaxial lead in which three conductors, 324, 326 and 328 are located coaxially within insulative lead body 304. Each of these conductors is coupled to one of defibrillation electrode 330, ring electrode 332 or helical elec~rode 334. With the exception of the omission of the J-shaped bend, lead 303 corresponds exactly to lead 101, illustrated in Figure 1.
As illustrated, this electrode system is provided with electrodes 332 and 334 allowing for sensing of ventricular electrical activity, but is not provided with a separate set of electrodes for sensing electrical activity in the atrium.
As such, as illustrated, it is anticipated that the cardioverter/defibrillator 300 will automatically delivery high voltage pulses between electrode 330 and electrode 312 in response to detection of ventricular tachycardia or fi~rillation. ~owever, delivery of atrial cardioversion or defibrillation pulses between electrode 306 and electrode 312 would be triggered externally by the patient or a physician in response to detection of symptoms indicative of atrial fibrillation or atrial tachycardia. In such an embodiment, an internal averride disabling the ability to trigger atrial cardioversion/defibrillation shocks may be desirable in response to internal detection of electrical WO 92/14512 PCT/US91/0~
2101~;b activity which is reliably identified as ventricular tachycardia or ventricular fibrillation rather than rapid ventricular rates due to atrial fibrillation or atrial tachycardia.
Figure 4 is a cutaway view of the heart illustrating yet another embodiment of the present invention~ This embodiment includes a lead 401, which has defibrillation electrodes 406 and 430 mounted to its insulative lead body 402, and located in the right atrium and right ventricular, respectively. The lead also includes a helical electrode 434, corresponding to the helical electrode 110, illustrated in conjunction with lead 101, Figure 1. As in the case of lead 101, illustrated in Figure 1, lead 401 is a coaxial, tripolar lead having coaxial conductors 420, 424 and 426 : 15 coupled to electrodes 406, 430 and 434. Lead 403 corresponds exactly to lead 203, illustrated in Figure 2 and is provided with ring electrodes 408 and 410 and with a defibrillation electrode, each coupled to one of three conductors 416, 418 and 420. It is anticipated that in some cases, this electrode configuration will be practiced by employing a lead as disclosed in the above ~ited Mirowski patent, employing right ventricular and SVC electrodes in ~ conjunction with a coronary sinus lead as disclosed in the .: above cited Mehra application.
In this embodiment, the defibrillator/cardioverter 400 is configured such that it may sense electrical activity in : the atrium via electrodes 408 and 410 and may sense . electrical activity in the ventricular via electrode 434 anda remote, different electrode, or ~etween electrode 434 and electrode 430. In response to dete_tion of ventricular ~achycardia, cardioverter/defibrillator 400 generates a high voltage pulse between electrodes 430 and 412. In response to detection of atrial tachycardia or fibrillation, defibrillator/cardioverter 400 delivers a high voltage between electrodes 406 and 412. As such, the lead system , . , . , , , , . .. . _ _ .
J
~' ':~
210 1 8 4 6 ' 12 PCT/US91/O~U~
illustrated is particular~y beneficial if atrial ~nd ventricular cardioversion and defibrillation f~nctions are desired to be co~bined within the same device. Selection between electrodes 406 and 430 may be accomplished using a defibrillation/cardioversion pulse generator as disclosed in the above-cited Keimel et al. application, or using other defibrillation pulse generators capable of being programmed to deliver pulses between multiple pairs of electrodes, as disclosed in the article "A Multielectrode - Time Sequential Laboratory Defibrillator for the Study of Implanted Electrode Systems", by Schuder et al, published in Transactions of the American Societv of Artificial Oraans, Vol. XVIII, pp 514-519, 1972, incorporated herein by reference in its entirety.
The inventive atrial cardioversion and defibrillation lead system is shown in conjunction with an endocardial ventricular electrode, if ventricular defibrillation capabilities are desired. However, the endocardial ventricular electrode may be replaced by or augmented with a , 20 subcutaneous patch electrode, which may correspond to any of ¦ the previously known subcutaneous patch electrodes.
I Alternatively, if the atrial defibrillation system is to be I added to a previously existing ventricular defibrillation j lead system, the endocardial ventricular electrode may be substituted with a left ventricular epicardial electrode.
Appropriate epicardial electrodes are illustrated in U.S. Patent No. 4,817,634, issued April 4, 1989 to Holleman, et al, and incorporatèd herein by reference in its entirety.
Appropriate subcutaneous electrodes may take the form of the electrodes illustrated in U.S. Patent Application Serial No.
07/376,730 by Lindemans et al, filed July 7, 1989 for a ~ "patch electrode", also incorporated herein by reference in - its entirety. The location of the subcutaneous elect~ode will vary from patient to patient, depending upon the particular geo~etry o~ the patient's heart, the other WO 92/14512 PCT/US91/~&~
electrodes present and other considerations of bodily structure.
As discussed above, the electrode system and its method of application may be beneficially practiced in a wide variety of contexts, including automatic and nonautomatic cardioverters and defibrillators, which may or m~y not include additional electrodes dedicated toward provision of ventricular defibrillation pulses. Similarly, the electrodes employed to perform atrial defibrillation may be ~0 located on leads having a wide variety of configurations.
While some of the configurations illustrated are specifically claimed below, these particular configurations should not be considered limiting with regard to claims to the general method set forth above or claims directed generally to lead systems appropriate for carrying out the claimed method. As such, the above illustrated embodiments should be considered exemplary, rather than limiting with regard to the claims presented below. In conjunction with the above disclosure, I c'aim:
!
)
Figure 2 is a cutaway view of the h~man heart illustrating an alternative embodiment of the present invention employing an atrial lead having a generally straight defibrillation electrode 206 and a coronary sinus defibrillation lead 203 provided with sensing electrodes 208 and 210. The electrode lead 203 may correspond to the coronary sinus defibrillation lead illustrated in F~gure 2 of allowed U.S. Patent Application Serial No. 07/284,957, filed December 15, 19~8 by Mehra, for an "Endocardial Defibrillation Electrode System" incorporated herein by reference. LiXe the atrial lead lOl discussed in conjunction with Figure l, lead 203 has a tripolar configuration, employing three coaxial conductors 116, 118 and 120, each coupled to one of electrodes 208, 210 and WO 92/14512 21 018 4 ~ PCT/US91/08 ~
electrode 2~2, indicated in broken out line within the coronary sinus. Electrodes 208 and 210 function to sense the electrical activity of the atrium for defibrillation detection and/or cardiac pacing.
Electrode lead 201 corresponds to the lead illustrated in Figure 2 of the above-cited allowed application by Mehra et al., however it omits sensing electrodes corresponding to electrodes 208 and 2lO, and includes only a single conductor 122, mounted within insulative lead body 202, coupled to electrodes 206. A pliant insulative tip 124 is visible. A
corresponding pliant, insulative tip is located on the distal end of lead 203, not visible in this view and on the distal end of lead lOl, Fig. l. As in the case of electrode 106, Fig. l, electrode 206 may extend proximally into the superior vena cava or may be located predominantly in the superior vena cava.
The construction of electrodes 206 and 212 corresponds to the construction of electrodes 106 and ll~, as discussed above in conjunction with Figure l. As in the case of the system illustrated in Figure l, defibrillatortcardioverter 200 delivers defibrillation pulses between electrodes 206 and 212, either in response to detection of atrial tachycardia or fibrillation via electrodes 208 and 210 or in response to an external command signal.
Figure 3 is a cutaway view of the heart illustrating yet another embodiment of an electrode ~ystem embodying the present invention . In this embodiment, a first electrode , lead 301 is pro~ided with two defibrillation electrodes 306 and 312, both located around its insulative lead body 302.
Lead 301 is a bipolar lead, employing two conductors 320 and 322 located coaxially within lead body 302. Electrodes 306 and 312 may correspond to electrodes 106 ~d 112, illustrated in Figure l. Electro~e 306 is provided with a preformed, J-shaped configuration corresponding to that of electrode 106, illustrated in Figure l which assists both in ., , ~J
, ~ , . _ .
f , .
;:~
21 D 1 ~ 4 6 PCT/US91/08 ~
~aintaining the lead in its location within the heart and allows for a substantial surface area of the electrode 306 to be located in the right atrium, while remaining spaced from the ostium of the coronary sinus. Electrode 312 is located within the coronary sinus and great vein also, spaced from the ostium of the coronary sinus. An interelectrode spacing of at least about 5_cm is believed desirable. This assists in providing good intraelectrode separation between electrode 306 and 312. As a practical matter, this interelectrode spacing may result in electrode 306 being predominantly located in the superior vena cava in some patients.
A second lead 303 is provided which is also triaxial lead in which three conductors, 324, 326 and 328 are located coaxially within insulative lead body 304. Each of these conductors is coupled to one of defibrillation electrode 330, ring electrode 332 or helical elec~rode 334. With the exception of the omission of the J-shaped bend, lead 303 corresponds exactly to lead 101, illustrated in Figure 1.
As illustrated, this electrode system is provided with electrodes 332 and 334 allowing for sensing of ventricular electrical activity, but is not provided with a separate set of electrodes for sensing electrical activity in the atrium.
As such, as illustrated, it is anticipated that the cardioverter/defibrillator 300 will automatically delivery high voltage pulses between electrode 330 and electrode 312 in response to detection of ventricular tachycardia or fi~rillation. ~owever, delivery of atrial cardioversion or defibrillation pulses between electrode 306 and electrode 312 would be triggered externally by the patient or a physician in response to detection of symptoms indicative of atrial fibrillation or atrial tachycardia. In such an embodiment, an internal averride disabling the ability to trigger atrial cardioversion/defibrillation shocks may be desirable in response to internal detection of electrical WO 92/14512 PCT/US91/0~
2101~;b activity which is reliably identified as ventricular tachycardia or ventricular fibrillation rather than rapid ventricular rates due to atrial fibrillation or atrial tachycardia.
Figure 4 is a cutaway view of the heart illustrating yet another embodiment of the present invention~ This embodiment includes a lead 401, which has defibrillation electrodes 406 and 430 mounted to its insulative lead body 402, and located in the right atrium and right ventricular, respectively. The lead also includes a helical electrode 434, corresponding to the helical electrode 110, illustrated in conjunction with lead 101, Figure 1. As in the case of lead 101, illustrated in Figure 1, lead 401 is a coaxial, tripolar lead having coaxial conductors 420, 424 and 426 : 15 coupled to electrodes 406, 430 and 434. Lead 403 corresponds exactly to lead 203, illustrated in Figure 2 and is provided with ring electrodes 408 and 410 and with a defibrillation electrode, each coupled to one of three conductors 416, 418 and 420. It is anticipated that in some cases, this electrode configuration will be practiced by employing a lead as disclosed in the above ~ited Mirowski patent, employing right ventricular and SVC electrodes in ~ conjunction with a coronary sinus lead as disclosed in the .: above cited Mehra application.
In this embodiment, the defibrillator/cardioverter 400 is configured such that it may sense electrical activity in : the atrium via electrodes 408 and 410 and may sense . electrical activity in the ventricular via electrode 434 anda remote, different electrode, or ~etween electrode 434 and electrode 430. In response to dete_tion of ventricular ~achycardia, cardioverter/defibrillator 400 generates a high voltage pulse between electrodes 430 and 412. In response to detection of atrial tachycardia or fibrillation, defibrillator/cardioverter 400 delivers a high voltage between electrodes 406 and 412. As such, the lead system , . , . , , , , . .. . _ _ .
J
~' ':~
210 1 8 4 6 ' 12 PCT/US91/O~U~
illustrated is particular~y beneficial if atrial ~nd ventricular cardioversion and defibrillation f~nctions are desired to be co~bined within the same device. Selection between electrodes 406 and 430 may be accomplished using a defibrillation/cardioversion pulse generator as disclosed in the above-cited Keimel et al. application, or using other defibrillation pulse generators capable of being programmed to deliver pulses between multiple pairs of electrodes, as disclosed in the article "A Multielectrode - Time Sequential Laboratory Defibrillator for the Study of Implanted Electrode Systems", by Schuder et al, published in Transactions of the American Societv of Artificial Oraans, Vol. XVIII, pp 514-519, 1972, incorporated herein by reference in its entirety.
The inventive atrial cardioversion and defibrillation lead system is shown in conjunction with an endocardial ventricular electrode, if ventricular defibrillation capabilities are desired. However, the endocardial ventricular electrode may be replaced by or augmented with a , 20 subcutaneous patch electrode, which may correspond to any of ¦ the previously known subcutaneous patch electrodes.
I Alternatively, if the atrial defibrillation system is to be I added to a previously existing ventricular defibrillation j lead system, the endocardial ventricular electrode may be substituted with a left ventricular epicardial electrode.
Appropriate epicardial electrodes are illustrated in U.S. Patent No. 4,817,634, issued April 4, 1989 to Holleman, et al, and incorporatèd herein by reference in its entirety.
Appropriate subcutaneous electrodes may take the form of the electrodes illustrated in U.S. Patent Application Serial No.
07/376,730 by Lindemans et al, filed July 7, 1989 for a ~ "patch electrode", also incorporated herein by reference in - its entirety. The location of the subcutaneous elect~ode will vary from patient to patient, depending upon the particular geo~etry o~ the patient's heart, the other WO 92/14512 PCT/US91/~&~
electrodes present and other considerations of bodily structure.
As discussed above, the electrode system and its method of application may be beneficially practiced in a wide variety of contexts, including automatic and nonautomatic cardioverters and defibrillators, which may or m~y not include additional electrodes dedicated toward provision of ventricular defibrillation pulses. Similarly, the electrodes employed to perform atrial defibrillation may be ~0 located on leads having a wide variety of configurations.
While some of the configurations illustrated are specifically claimed below, these particular configurations should not be considered limiting with regard to claims to the general method set forth above or claims directed generally to lead systems appropriate for carrying out the claimed method. As such, the above illustrated embodiments should be considered exemplary, rather than limiting with regard to the claims presented below. In conjunction with the above disclosure, I c'aim:
!
)
Claims (7)
1. A method of cardioverting or defibrillating the heart, comprising;
transvenously inserting a first elongated electrode into the great vein and coronary sinus of a heart;
transvenously inserting a second elongated electrode into the vicinity of the atrium of said heart, spaced from said first electrode; and delivering a cardioversion or defibrillation pulse between said first and second electrodes.
transvenously inserting a first elongated electrode into the great vein and coronary sinus of a heart;
transvenously inserting a second elongated electrode into the vicinity of the atrium of said heart, spaced from said first electrode; and delivering a cardioversion or defibrillation pulse between said first and second electrodes.
2. A method according to claim 1 wherein said first and second electrodes are located on first and second electrical leads and wherein said step of inserting said first electrode comprises inserting said first lead and wherein said step of inserting said second electrode comprises inserting said second lead.
3. A method according to claim 1 wherein said first and second electrodes are located on a single electrical lead and wherein said steps of inserting said first electrode and inserting said second electrode comprise inserting said lead such that said lead passes through the atrium of said heart and terminates in the great vein of said heart.
4. A method according to claim 1 or claim 2 or claim 3 wherein said step of inserting said first electrode comprises inserting said first electrode entirely within the coronary sinus and great vein of said heart and spaced from the opening of the coronary sinus into the atrium of said heart.
5. A method according to claim 1 or claim 2 or claim 3 wherein said step of inserting said second electrode comprises the step of inserting said second electrode into the atrium of said heart spaced from the opening of the coronary sinus into the atrium of said heart.
6. A method according to claim 1 or claim 2 or claim 3 further comprising locating a third electrode in or on the ventricles of said heart and wherein said step of delivering said cardioversion or defibrillation pulse comprises delivering said pulse only between said first and second electrodes.
7. A method according to claim 1 or claim 2 or claim 3 wherein said steps of inserting said first electrode and inserting said second electrode comprise inserting said first and second electrodes such that such that said first and second electrodes are spaced from one another and are located on opposite sides of the opening of the coronary sinus into the atrium of said heart.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US661,568 | 1991-02-26 | ||
| US07/661,568 US5165403A (en) | 1991-02-26 | 1991-02-26 | Difibrillation lead system and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2101846A1 true CA2101846A1 (en) | 1992-08-27 |
Family
ID=24654150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002101846A Abandoned CA2101846A1 (en) | 1991-02-26 | 1991-11-19 | Defibrillation lead system and method of use |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5165403A (en) |
| AU (1) | AU652405B2 (en) |
| CA (1) | CA2101846A1 (en) |
| WO (1) | WO1992014512A1 (en) |
Families Citing this family (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5433729A (en) * | 1991-04-12 | 1995-07-18 | Incontrol, Inc. | Atrial defibrillator, lead systems, and method |
| US5282837A (en) * | 1991-04-12 | 1994-02-01 | Incontrol, Inc. | Atrial defibrillator and method |
| US5509411A (en) * | 1993-01-29 | 1996-04-23 | Cardima, Inc. | Intravascular sensing device |
| US5699796A (en) * | 1993-01-29 | 1997-12-23 | Cardima, Inc. | High resolution intravascular signal detection |
| US5439481A (en) * | 1992-02-26 | 1995-08-08 | Angeion Corporation | Semi-automatic atrial and ventricular cardioverter defibrillator |
| US5649974A (en) * | 1992-07-27 | 1997-07-22 | Angeion Corporation | Low profile defibrillation catheter |
| US5454839A (en) * | 1992-07-27 | 1995-10-03 | Angeion Corporation | Low profile defibrillation catheter |
| US5292338A (en) * | 1992-07-30 | 1994-03-08 | Medtronic, Inc. | Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use |
| US5267559A (en) * | 1992-10-23 | 1993-12-07 | Incontrol, Inc. | Atrial defibrillator and method for providing atrial sensing |
| US5265600A (en) * | 1992-10-23 | 1993-11-30 | Incontrol, Inc. | Atrial defibrillator and method for providing post-cardioversion pacing |
| US5207219A (en) * | 1992-10-23 | 1993-05-04 | Incontrol, Inc. | Atrial defibrillator and method for providing interval timing prior to cardioversion |
| US5282836A (en) * | 1992-10-23 | 1994-02-01 | Incontrol, Inc. | Atrial defibrillator and method for providing pre-cardioversion pacing |
| US5269298A (en) * | 1992-10-23 | 1993-12-14 | Incontrol, Inc. | Atrial defibrillator and method for providing synchronized delayed cardioversion |
| US5496362A (en) * | 1992-11-24 | 1996-03-05 | Cardiac Pacemakers, Inc. | Implantable conformal coil patch electrode with multiple conductive elements for cardioversion and defibrillation |
| SE9203735D0 (en) * | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | ELECTRIC SYSTEM FOR DEFIBRILLATOR |
| US5395373A (en) * | 1993-01-07 | 1995-03-07 | Incontrol, Inc. | Atrial defibrillator and method for setting energy threshold values |
| US5403351A (en) * | 1993-01-11 | 1995-04-04 | Saksena; Sanjeev | Method of transvenous defibrillation/cardioversion employing an endocardial lead system |
| US5645082A (en) * | 1993-01-29 | 1997-07-08 | Cardima, Inc. | Intravascular method and system for treating arrhythmia |
| EP0681451B1 (en) * | 1993-01-29 | 2001-09-05 | Cardima, Inc. | Multiple intravascular sensing devices for electrical activity |
| DE69326080T2 (en) * | 1993-02-01 | 2000-03-09 | Gore & Ass | IMPLANTABLE ELECTRODE |
| US5792187A (en) | 1993-02-22 | 1998-08-11 | Angeion Corporation | Neuro-stimulation to control pain during cardioversion defibrillation |
| IT1271458B (en) * | 1993-03-08 | 1997-05-28 | Leonardo Cammilli | SEQUENTIAL CARDIAC STIMULATION (DDD) SYSTEM WITH THE USE OF A SINGLE LEAD INSERTED THROUGH THE CORONARY BREAST. |
| US5314430A (en) * | 1993-06-24 | 1994-05-24 | Medtronic, Inc. | Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use |
| US5643231A (en) * | 1993-08-13 | 1997-07-01 | Daig Corporation | Coronary sinus catheter |
| US5423772A (en) * | 1993-08-13 | 1995-06-13 | Daig Corporation | Coronary sinus catheter |
| US6001085A (en) * | 1993-08-13 | 1999-12-14 | Daig Corporation | Coronary sinus catheter |
| US5984909A (en) * | 1993-08-13 | 1999-11-16 | Daig Corporation | Coronary sinus catheter |
| US5466254A (en) * | 1993-09-22 | 1995-11-14 | Pacesetter, Inc. | Coronary sinus lead with atrial sensing capability |
| AU7924694A (en) * | 1993-10-01 | 1995-05-01 | Target Therapeutics, Inc. | Sheathed multipolar catheter and multipolar guidewire for sensing cardiac electrical activity |
| US5641326A (en) * | 1993-12-13 | 1997-06-24 | Angeion Corporation | Method and apparatus for independent atrial and ventricular defibrillation |
| US5486198A (en) * | 1994-08-12 | 1996-01-23 | Ayers; Gregory M. | Atrial defibrillator and method for providing interval timing of successive intervals prior to cardioversion |
| US5549642A (en) * | 1994-08-19 | 1996-08-27 | Medtronic, Inc. | Atrial defibrillator and method of use |
| US5601608A (en) * | 1995-02-02 | 1997-02-11 | Pacesetter, Inc. | Methods and apparatus for applying charge-balanced antiarrhythmia shocks |
| US5630834A (en) * | 1995-05-03 | 1997-05-20 | Medtronic, Inc. | Atrial defibrillator with means for delivering therapy in response to a determination that the patient is likely asleep |
| US5713924A (en) * | 1995-06-27 | 1998-02-03 | Medtronic, Inc. | Defibrillation threshold reduction system |
| US5609621A (en) * | 1995-08-04 | 1997-03-11 | Medtronic, Inc. | Right ventricular outflow tract defibrillation lead |
| US5662689A (en) * | 1995-09-08 | 1997-09-02 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain |
| DE29603805U1 (en) | 1996-03-01 | 1997-07-03 | Michel Ulrich Dipl Ing | Device for transvenous cardioversion of atrial fibrillation or atrial flutter |
| US5755761A (en) * | 1996-04-26 | 1998-05-26 | Pharmatarget, Inc. | Atrial pacing catheter and method having multiple electrodes in the right atrium and coronary sinus |
| US5690686A (en) * | 1996-04-30 | 1997-11-25 | Medtronic, Inc. | Atrial defibrillation method |
| US5683429A (en) * | 1996-04-30 | 1997-11-04 | Medtronic, Inc. | Method and apparatus for cardiac pacing to prevent atrial fibrillation |
| US5720768A (en) * | 1996-05-22 | 1998-02-24 | Sulzer Intermedics Inc. | Dual chamber pacing with interchamber delay |
| US5987354A (en) | 1996-08-13 | 1999-11-16 | Uab Research Foundation | Dual shock atrial defibrillation apparatus |
| US6006131A (en) * | 1996-08-13 | 1999-12-21 | Uab Research Foundation | Dual current pathway atrial defibrillation apparatus |
| US5810887A (en) * | 1996-08-23 | 1998-09-22 | Rhythm Technologies, Inc. | Temporary catheter |
| US5800464A (en) | 1996-10-03 | 1998-09-01 | Medtronic, Inc. | System for providing hyperpolarization of cardiac to enhance cardiac function |
| US6038472A (en) * | 1997-04-29 | 2000-03-14 | Medtronic, Inc. | Implantable defibrillator and lead system |
| US5978704A (en) * | 1997-06-03 | 1999-11-02 | Uab Research Foundation | Method and apparatus for treating cardiac arrhythmia |
| US6067471A (en) | 1998-08-07 | 2000-05-23 | Cardiac Pacemakers, Inc. | Atrial and ventricular implantable cardioverter-defibrillator and lead system |
| US6321122B1 (en) | 1998-07-22 | 2001-11-20 | Cardiac Pacemakers, Inc. | Single pass defibrillation/pacing lead with passively attached electrode for pacing and sensing |
| US6501994B1 (en) | 1997-12-24 | 2002-12-31 | Cardiac Pacemakers, Inc. | High impedance electrode tip |
| US6212434B1 (en) | 1998-07-22 | 2001-04-03 | Cardiac Pacemakers, Inc. | Single pass lead system |
| US6085119A (en) * | 1998-07-22 | 2000-07-04 | Cardiac Pacemakers, Inc. | Single pass endocardial lead for multi-site atrial pacing |
| US6152954A (en) | 1998-07-22 | 2000-11-28 | Cardiac Pacemakers, Inc. | Single pass lead having retractable, actively attached electrode for pacing and sensing |
| US5964795A (en) * | 1998-03-13 | 1999-10-12 | Medtronic, Inc. | Medical electrical lead |
| US6556862B2 (en) | 1998-03-19 | 2003-04-29 | Cardiac Pacemakers, Inc. | Method and apparatus for treating supraventricular tachyarrhythmias |
| US6714823B1 (en) | 1998-04-29 | 2004-03-30 | Emory University | Cardiac pacing lead and delivery system |
| US6501990B1 (en) | 1999-12-23 | 2002-12-31 | Cardiac Pacemakers, Inc. | Extendable and retractable lead having a snap-fit terminal connector |
| US6463334B1 (en) | 1998-11-02 | 2002-10-08 | Cardiac Pacemakers, Inc. | Extendable and retractable lead |
| US6243603B1 (en) | 1998-09-15 | 2001-06-05 | Uab Research Foundation | Methods and apparatus for detecting medical conditions of the heart |
| US6219582B1 (en) | 1998-12-30 | 2001-04-17 | Daig Corporation | Temporary atrial cardioversion catheter |
| US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
| US7507252B2 (en) | 2000-01-31 | 2009-03-24 | Edwards Lifesciences Ag | Adjustable transluminal annuloplasty system |
| US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
| US6456876B1 (en) * | 2000-02-28 | 2002-09-24 | Pacesetter, Inc. | Dual-chamber implantable cardiac stimulation system and device with selectable arrhythmia termination electrode configurations and method |
| US6847842B1 (en) | 2000-05-15 | 2005-01-25 | Cardiac Pacemakers, Inc. | Method and apparatus for reducing early recurrence of atrial fibrillation with defibrillation shock therapy |
| US6584362B1 (en) | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
| US6493586B1 (en) * | 2000-08-30 | 2002-12-10 | Cardiac Pacemakers, Inc. | Site reversion in cardiac rhythm management |
| US6484057B2 (en) | 2000-12-21 | 2002-11-19 | Uab Research Foundation | Pacing methods and devices for treating cardiac arrhythmias and fibrillation |
| US6480740B2 (en) | 2000-12-26 | 2002-11-12 | Cardiac Pacemakers, Inc. | Safety pacing in multi-site CRM devices |
| US7510576B2 (en) | 2001-01-30 | 2009-03-31 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
| US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
| US6571125B2 (en) | 2001-02-12 | 2003-05-27 | Medtronic, Inc. | Drug delivery device |
| US6829506B2 (en) * | 2001-07-25 | 2004-12-07 | Cardiac Pacemakers, Inc. | Linear stimulation of the heart for improved hemodynamic benefit |
| US7027861B2 (en) | 2001-10-09 | 2006-04-11 | Medtronic, Inc. | Method and apparatus for affecting atrial defibrillation with bi-atrial pacing |
| US6980858B2 (en) * | 2001-12-31 | 2005-12-27 | Biosense Webster, Inc. | Method and system for atrial defibrillation |
| US7139608B2 (en) * | 2002-07-31 | 2006-11-21 | Uab Research Foundation | Pacing methods and devices using feedback controlled timing |
| US7142927B2 (en) * | 2002-09-04 | 2006-11-28 | Uab Research Foundation | Method and system for the selection of cardiac defibrillation shocks based on discomfort |
| US7162298B2 (en) * | 2002-09-10 | 2007-01-09 | Uab Research Foundation | Devices for detecting the presence of cardiac activity following administration of defibrillation therapy |
| US20040049118A1 (en) * | 2002-09-10 | 2004-03-11 | Ideker Raymond E. | Methods, systems and computer program products for treating fibrillation in a patient based on the presence of fibrillation following administration of defibrillation therapy |
| US8560063B2 (en) * | 2002-09-10 | 2013-10-15 | Uab Research Foundation | Post-defibrillation pacing methods and devices |
| CA2442352A1 (en) * | 2002-09-26 | 2004-03-26 | Reg Macquarrie | Poly-(vinyl alcohol) based meat processing films |
| US7522958B2 (en) * | 2003-03-13 | 2009-04-21 | Uab Research Foundation | Methods and systems for reducing discomfort from cardiac defibrillation shocks |
| US20040210256A1 (en) * | 2003-04-17 | 2004-10-21 | Medtronic, Inc. | Methods and apparatus for decreasing incidences of early recurrence of atrial fibrillation |
| US7006864B2 (en) * | 2003-06-17 | 2006-02-28 | Ebr Systems, Inc. | Methods and systems for vibrational treatment of cardiac arrhythmias |
| US7231249B2 (en) * | 2003-07-24 | 2007-06-12 | Mirowski Family Ventures, L.L.C. | Methods, apparatus, and systems for multiple stimulation from a single stimulator |
| US7184830B2 (en) * | 2003-08-18 | 2007-02-27 | Ebr Systems, Inc. | Methods and systems for treating arrhythmias using a combination of vibrational and electrical energy |
| US20050055057A1 (en) * | 2003-09-05 | 2005-03-10 | Mirowski Famliy Ventures, L.L.C. | Method and apparatus for providing ipselateral therapy |
| US20050055058A1 (en) * | 2003-09-08 | 2005-03-10 | Mower Morton M. | Method and apparatus for intrachamber resynchronization |
| US7050849B2 (en) * | 2003-11-06 | 2006-05-23 | Ebr Systems, Inc. | Vibrational therapy device used for resynchronization pacing in a treatment for heart failure |
| US7734344B2 (en) | 2003-12-02 | 2010-06-08 | Uab Research Foundation | Methods, systems and computer program products to inhibit ventricular fibrillation during cardiopulmonary resuscitation |
| US7765001B2 (en) | 2005-08-31 | 2010-07-27 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
| US7558631B2 (en) * | 2004-12-21 | 2009-07-07 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
| WO2006069327A2 (en) * | 2004-12-21 | 2006-06-29 | Ebr Systems, Inc. | Implantable transducer devices |
| EP1835964B1 (en) * | 2004-12-21 | 2016-03-09 | EBR Systems, Inc. | Leadless cardiac system for pacing and arrhythmia treatment |
| US7702392B2 (en) | 2005-09-12 | 2010-04-20 | Ebr Systems, Inc. | Methods and apparatus for determining cardiac stimulation sites using hemodynamic data |
| US20080103572A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical lead with threaded fixation |
| US8718773B2 (en) | 2007-05-23 | 2014-05-06 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
| US7953493B2 (en) | 2007-12-27 | 2011-05-31 | Ebr Systems, Inc. | Optimizing size of implantable medical devices by isolating the power source |
| EP2265166B1 (en) | 2008-03-25 | 2020-08-05 | EBR Systems, Inc. | Temporary electrode connection for wireless pacing systems |
| US20100016911A1 (en) | 2008-07-16 | 2010-01-21 | Ebr Systems, Inc. | Local Lead To Improve Energy Efficiency In Implantable Wireless Acoustic Stimulators |
| WO2010030904A2 (en) * | 2008-09-11 | 2010-03-18 | Mayo Foundation For Medical Education And Research | Central core multifunctional cardiac devices |
| GB2519302B (en) | 2013-10-15 | 2016-04-20 | Gloucestershire Hospitals Nhs Foundation Trust | Apparatus for artificial cardiac stimulation and method of using the same |
| EP3377171B1 (en) | 2015-11-20 | 2022-11-09 | Cardiac Pacemakers, Inc. | Single pass coronary venous lead for multiple chamber sense and pace |
| US11565121B2 (en) * | 2017-03-28 | 2023-01-31 | Inter Nova Medical Co., Ltd. | Compound electrode-type intracardiac defibrillation catheter and compound electrode-type intracardiac defibrillation catheter unit |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3729008A (en) * | 1970-12-28 | 1973-04-24 | American Optical Corp | Electrode for atrial pacing with curved end for atrial wall engagement |
| US4332259A (en) * | 1979-09-19 | 1982-06-01 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
| US4402330A (en) * | 1979-09-24 | 1983-09-06 | Medtronic, Inc. | Body implantable lead |
| US4727877A (en) * | 1984-12-18 | 1988-03-01 | Medtronic, Inc. | Method and apparatus for low energy endocardial defibrillation |
| US5007436A (en) * | 1985-06-20 | 1991-04-16 | Medtronic, Inc. | Cardioversion and defibrillation lead system |
| US4953551A (en) * | 1987-01-14 | 1990-09-04 | Medtronic, Inc. | Method of defibrillating a heart |
| US4817634A (en) * | 1987-06-18 | 1989-04-04 | Medtronic, Inc. | Epicardial patch electrode |
| US4932407A (en) * | 1988-12-15 | 1990-06-12 | Medtronic, Inc. | Endocardial defibrillation electrode system |
-
1991
- 1991-02-26 US US07/661,568 patent/US5165403A/en not_active Expired - Lifetime
- 1991-11-19 AU AU90653/91A patent/AU652405B2/en not_active Ceased
- 1991-11-19 CA CA002101846A patent/CA2101846A1/en not_active Abandoned
- 1991-11-19 WO PCT/US1991/008665 patent/WO1992014512A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992014512A1 (en) | 1992-09-03 |
| AU9065391A (en) | 1992-09-15 |
| AU652405B2 (en) | 1994-08-25 |
| US5165403A (en) | 1992-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5165403A (en) | Difibrillation lead system and method of use | |
| US6157862A (en) | Shaped multiple electrode lead for implantable device | |
| US5144960A (en) | Transvenous defibrillation lead and method of use | |
| US5014696A (en) | Endocardial defibrillation electrode system | |
| US5099838A (en) | Endocardial defibrillation electrode system | |
| US4932407A (en) | Endocardial defibrillation electrode system | |
| US5928269A (en) | Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes | |
| EP0652789B1 (en) | Atrial defibrillator employing transvenous and subcutaneous electrodes | |
| US5314430A (en) | Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use | |
| US5549642A (en) | Atrial defibrillator and method of use | |
| US5261400A (en) | Defibrillator employing transvenous and subcutaneous electrodes and method of use | |
| JP4430744B2 (en) | Implantable system for patients in need of such treatment with cardiac cardioversion | |
| US5403351A (en) | Method of transvenous defibrillation/cardioversion employing an endocardial lead system | |
| US6327498B1 (en) | Implantable stimulation lead for use with an ICD device having automatic capture pacing features | |
| US5456706A (en) | Cardiac defibrillation lead having defibrillation and atrial sensing electrodes | |
| JP3490756B2 (en) | Intravenous lead | |
| US5690686A (en) | Atrial defibrillation method | |
| US5050601A (en) | Cardiac defibrillator electrode arrangement | |
| EP0373953A2 (en) | Endocardial defibrillation electrode system | |
| JPH02307482A (en) | Catheter type lead wire for intravena | |
| US20050038474A1 (en) | Implantable automatic defibrillator with subcutaneous electrodes | |
| US6181967B1 (en) | Atrial defibrillator apparatus and method of use | |
| Zipes et al. | Synchronous intracardiac cardioversion | |
| JPH01288273A (en) | Intravenous catheter type lead wire |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |